Genexine ranked among the top searched stocks for 3 days within the past month.

As of 9:30 AM on the 23rd, Genexine is trading at 98,500 KRW, down 2.18% from the previous day. This represents a 32.57% increase compared to May 26. Genexine is known as a specialized company in the development of biopharmaceuticals.

Over the past 5 days, individual investors have net purchased 654,750 shares, while foreigners and institutions have net sold 40,350 shares and 45,809 shares, respectively.

On June 19, Genexine became a market issue with the news of the "first domestic" COVID-19 vaccine administered to humans, causing a "surge."

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing